Health

Results: 1501-1512 of 9520

PR Newswire associated0

LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility

PR Newswire associated0

Pierre Fabre Laboratories is exploring the potential of Artificial Intelligence to launch a new generation of clinical studies in dermo-cosmetics

PR Newswire associated0

IotaMotion Strengthens Leadership Position in Robotic Cochlear Implant Surgery with Issuance of New U.S. Patent

Andersen Consulting Strengthens Platform with Collaborating Firm Ambit Iberia

PR Newswire associated0

DermRays Launches Lumenic™ Dual-Light & 3D-Oscillo™ System for At-Home Professional Teeth Whitening

PR Newswire associated0

Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR

PR Newswire associated0

WHO Foundation and Novo Nordisk Expand Collaboration to Provide Financial Support towards strengthening health systems for Cardio-Renal-Metabolic Diseases

Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program.

Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site

More dentists coming as government boosts number who can practise

Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health

Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples

Latest data on long-term, real-world treatment with lecanemab will be presented at the AD/PD™ 2026 congress